Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start Phase 2b human clinical trial in pancreatic cancer in some time. Before the trial begins, the company…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) released an educational article that will allow people to know about its technology and its application in pancreatic…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to discuss some of its major milestones right before the phase 2b clinical trial in pancreatic cancer…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) may not be as large as many other biotech firms around the world, but the innovative technologies used by it are…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) revealed that it finalized a contract with Imaging Endpoints in Arizona for completion of radiologic imaging process…

Leading biotech company Pharmacyte Biotech Inc (OTCMKTS:PMCB) is known for using high-end technologies to develop drugs for cancer and other diseases….

Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that its CEO, Mr. Kenneth L. Waggoner, JD expressed his views on the company’s development plans and talked…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) biotech entity in clinical stage working to advance targeted treatments for patients suffering from diabetes and…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that Chardan Capital Markets LLC, a global investment bank specializing in small, mid-cap and micro firms,…

So far in this year, there are some OTC listed biotech firms that have managed to fetch investors’ attention. One of such company is Pharmacyte Biotech…

SPYR banner1